<DOC>
	<DOCNO>NCT01135316</DOCNO>
	<brief_summary>Phase 4 , open-label , two-year , prospective , multi-center , follow-up study conduct 15 site USA . Approximately 1,000 patient moderate-to-severe CKD enrol follow 24 month .</brief_summary>
	<brief_title>Prospective Evaluation Incidence NSF Patients With Kidney Disease Undergoing MR</brief_title>
	<detailed_description>Phase 4 , open-label , two-year , prospective , multi-center , follow-up study conduct 15 active site United States . All patient receive 1 dose Ablavar part MRI examination routine clinical management . Prior undergo Ablavar MRI , patient baseline serum creatinine test within 24 hour prior Ablavar administration , sign Informed Consent ( IC ) form , undergo limited exam skin abnormality , undergo brief medical history assessment day prior Ablavar administration . A standardized NSF questionnaire administer patient 48 ( + -12 ) hour , 1 month ( + - 1 week ) , 3 month ( + - 2 week ) , 6 ( + - 1 ) month , 18 ( + - 1 ) month post-dose . At 12 ( + - 1 ) month , 24 ( + - 1 ) month . Patients return clinic limited examination skin abnormality formal review sign symptom suggestive NSF .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Nephrogenic Fibrosing Dermopathy</mesh_term>
	<criteria>Kidney Disease GFR &lt; 60 mL/min./1.73 m^2 . Clinical Need Receive MRI Contrast . Understand &amp; Sign Informed Consent . History know suspect NSF . Has receive gadolinium base contrast agent within 12 month prior enrollment . Has clinically significant skin disorder may interfere detection cutaneous NSF manifestation . Has medical condition circumstance would significantly decrease chance obtain reliable data achieve study objective . Is unable unwilling return necessary office visit follow call , and/or examine physician undergo deep skin biopsy development NSF suspect .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>NSF , Ablavar , Kidney Disease , Magnetic Resonance Imaging ( MRI ) ,</keyword>
</DOC>